Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Prostate Cancer

FDA Sets a Late-2026 Decision on Adding a PARP Inhibitor to Hormone Therapy for Advanced Prostate Cancer

FDA granted priority review to talazoparib plus enzalutamide for HRR-altered metastatic prostate cancer. A decision is expected in late 2026.

Medical Daily

The Small Prostate Cancer Trial Behind Adaptive Therapy, and the Dispute Over What It Proved

A Moffitt pilot trial of adaptive abiraterone dosing reported longer time to progression. A published critique says superiority is still unproven.

Medical Daily

Dermot Murnaghan’s friend recalls last cycle ride with TV presenter before prostate cancer death

The Sky News presenter is joining Sir Chris Hoy’s Tour de 4 charity ride in Murnaghan’s memory, having hoped that they would complete it together

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Dermot Murnaghan’s death hit friend and fellow broadcaster ‘like ton of bricks’

The former Eggheads quiz show host died aged 68 following a period of illness with prostate cancer.

Evening Standard

Scientists Found How Prostate Tumors Vanish from the Immune System's Radar and How to Make Them Visible Again

Duke scientists found the protein that hides prostate cancer from the immune system and a way to reverse it. Here is what the Nature Biomedical Engineering study found and what it means for immunotherapy.

Medical Daily

Treating Cancer Like an Evolving Ecosystem Could Beat Drug Resistance, New Mathematical Models Suggest

New mathematical models in Genetics published July 22 show that timed therapy switching before tumor regrowth could outperform maximum-dose cancer treatment by exploiting resistance evolution.

Medical Daily

Living With Metastatic Prostate Cancer: Bob Harris and His Cancer Story Highlights Advances in Modern Treatment

BBC broadcaster Bob Harris stepped down after revealing his prostate cancer has spread to his spine, highlighting why early detection can change outcomes.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

What Happens When Prostate Cancer Spreads? Edward Stourton's Death Highlights the Importance of Early Detection

Edward Stourton's death came after a long fight with prostate cancer, which prompted experts to urge men to heed the warning signs of this common disease.

Medical Daily

Researchers Develop a Fully Human Antibody That Halted Aggressive Prostate Cancer Growth and Spread in Lab Models

Umeå University researchers developed a fully human antibody that halted aggressive prostate cancer growth and spread in preclinical models. Here's what the early science shows.

Medical Daily

Jeremy Clarkson's Prostate Cancer Treatment Could Change How Millions of Men Are Treated, 10-Year Study Finds

Jeremy Clarkson's focal therapy for prostate cancer highlights new 10-year NHS research showing targeted treatment may match surgery and radiation outcomes while reducing urinary and sexual side effects.

Medical Daily

BBC broadcaster Edward Stourton dies aged 68

Corporation pays tribute to ‘outstanding’ journalist who presented shows including Today and One O’Clock News

The Guardian - UK

BBC presenter Edward Stourton dies aged 68

The journalist was diagnosed with prostate cancer in 2014 but continued to work until recently

The Independent UK

Six Cancer Drug Approvals in One Quarter: What the FDA Cleared in Q2 2026 and Who It Helps

FDA approved 6 cancer drugs in Q2 2026, covering breast, prostate, kidney, bladder, and blood cancers. Here's what was approved, who qualifies, and what it means.

Medical Daily

Minimally-invasive prostate cancer treatment used by Jeremy Clarkson has fewer side effects

IN FULL

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Prostate cancer treatment used by Jeremy Clarkson as effective as radiotherapy

The UK Government recently announced that extra funding would go towards expanding the provision of focal therapy

Evening Standard

Sir Chris Hoy joins tributes to ‘first class journalist’ Dermot Murnaghan

The veteran broadcaster died aged 68.

Evening Standard

News anchor Dermot Murnaghan 'died peacefully' after a 'period of illness with prostate cancer'

The veteran news anchor hosted Sky News, ITV Evening News, Channel 4 News and BBC News at Six during his five-decade career

Evening Standard

Dermot Murnaghan remembered as ‘legendary news journalist and presenter’

The media personality died ‘peacefully’ on Saturday morning ‘following a period of illness with prostate cancer’.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

TV presenter Dermot Murnaghan dies of prostate cancer, aged 68

The former ITV, BBC and Sky News journalist died peacefully at home in London on Saturday, his family say

Evening Standard

Former Sky News anchor Dermot Murnaghan dies aged 68

Murnaghan announced his ‘incurable but it’s not untreatable’ prostate cancer diagnosis last year.

The Independent UK

Dermot Murnaghan dies aged 68 after prostate cancer battle

IN FULL

The Independent UK

TV presenter Dermot Murnaghan dies aged 68 after prostate cancer diagnosis

Presenter had lamented his late diagnosis after his ‘silly’ decision to put off getting a routine PSA test

The National (Scotland)

Veteran TV news presenter Dermot Murnaghan dies aged 68

VETERAN TV presenter Dermot Murnaghan has died, aged 68.

Medical Daily

Lab Study Shows Silica Nanoparticles Wiped Out Aggressive Prostate Tumors in Mice When Combined with Immunotherapy

Silica nanoparticles destroyed aggressive prostate tumors in mice when combined with immunotherapy, a new Cornell study found. Here is what the early results mean.

Times Life

6 Prostate Health Habits Every Indian Man Over 40 Should Build Into His Daily Routine

Eat More Cooked TomatoesThe lycopene in tomatoes, the antioxidant that gives them their red colour, is more bioavailable after cooking than raw. The Harvard Health Professionals Follow-up Study found that men who consumed tomato-based foods more than twice a week had a 23% lower risk of prostate cancer compared to…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.